RUNX2 and cancer: Embryonic transcription factors that are re-activated in cancer, and RUNX2, despite being a typical regulator of osteogenesis, promotes metastasis through trans-differentiation processes like epithelial-to-mesenchymal transition (EMT) and osteomimicry [65].